Search research articles
Contact Us
Filters
Showing results (121-130 of 156) with videos related to
Page
of 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2024
Nivolumab in Patients with Metastatic Castration-Resistant Prostate Cancer with and without DNA Repair Defects
Pedro Isaacsson Velho, Diogo Assed Bastos, Pedro Tofani Saint'ana, et al.
Cancer
|
October 24, 2022
A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma
Rodrigo R Munhoz, Guilherme Nader-Marta, Veridiana P de Camargo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2022
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score
Barbara Burtness, Danny Rischin, Richard Greil, et al.
Cancer Research Communications
|
March 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials
Benjamin J Solomon, Daniel S W Tan, Gilberto de Castro, et al.
Critical Reviews in Oncology/Hematology
|
October 29, 2020
Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: A systematic review and meta-analysis
Bruno Augusto Linhares Almeida Mariz, Luiz Paulo Kowalski, William Nassib William, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 11, 2022
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study
Kevin J Harrington, Barbara Burtness, Richard Greil, et al.
Gland Surgery
|
May 21, 2026
Malignant salivary gland tumors in Brazil: epidemiology, treatment patterns, and survival outcomes in public Brazilian population
Aline Lauda Freitas Chaves, Leandro Luongo Matos, Patrícia Klarmann Ziegelmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 19, 2024
Sotorasib (960 mg or 240 mg) once daily in patients with previously treated KRAS G12C-mutated advanced NSCLC
Maximilian J Hochmair, Karim Vermaelen, Giannis Mountzios, et al.
Future Oncology (London, England)
|
July 25, 2019
ASTRIS: a global real-world study of osimertinib in >3000 patients with <i>EGFR</i> T790M positive non-small-cell lung cancer
Filippo de Marinis, Yi-Long Wu, Gilberto de Castro, et al.
JTO Clinical and Research Reports
|
October 4, 2022
Assessing Oncologists' Attitudes Concerning Comprehensive Genomic Profiling in Stage IV Lung Adenocarcinoma in Brazil
Aline F Fares, Pedro H Martinez, Pedro H Farina, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 156) with videos related to
Sort By:
Page
of 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2024
Nivolumab in Patients with Metastatic Castration-Resistant Prostate Cancer with and without DNA Repair Defects
Pedro Isaacsson Velho, Diogo Assed Bastos, Pedro Tofani Saint'ana, et al.
Cancer
|
October 24, 2022
A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma
Rodrigo R Munhoz, Guilherme Nader-Marta, Veridiana P de Camargo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2022
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score
Barbara Burtness, Danny Rischin, Richard Greil, et al.
Cancer Research Communications
|
March 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials
Benjamin J Solomon, Daniel S W Tan, Gilberto de Castro, et al.
Critical Reviews in Oncology/Hematology
|
October 29, 2020
Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: A systematic review and meta-analysis
Bruno Augusto Linhares Almeida Mariz, Luiz Paulo Kowalski, William Nassib William, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 11, 2022
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study
Kevin J Harrington, Barbara Burtness, Richard Greil, et al.
Gland Surgery
|
May 21, 2026
Malignant salivary gland tumors in Brazil: epidemiology, treatment patterns, and survival outcomes in public Brazilian population
Aline Lauda Freitas Chaves, Leandro Luongo Matos, Patrícia Klarmann Ziegelmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 19, 2024
Sotorasib (960 mg or 240 mg) once daily in patients with previously treated KRAS G12C-mutated advanced NSCLC
Maximilian J Hochmair, Karim Vermaelen, Giannis Mountzios, et al.
Future Oncology (London, England)
|
July 25, 2019
ASTRIS: a global real-world study of osimertinib in >3000 patients with <i>EGFR</i> T790M positive non-small-cell lung cancer
Filippo de Marinis, Yi-Long Wu, Gilberto de Castro, et al.
JTO Clinical and Research Reports
|
October 4, 2022
Assessing Oncologists' Attitudes Concerning Comprehensive Genomic Profiling in Stage IV Lung Adenocarcinoma in Brazil
Aline F Fares, Pedro H Martinez, Pedro H Farina, et al.
Page
of 16